Aplidin synergizes with cytosine arabinoside : functional relevance of mitochondria in Aplidin-induced cytotoxicity

R Humeniuk; L. G Menon; D Banerjee; P. J Mishra; G Saydam; G. S. A LONGO-SORBELLO; Y Elisseyeff; L. D Lewis; M Aracil; J Jimeno; J. R Bertino

doi:10.1038/sj.leu.2404911

Back

Aplidin synergizes with cytosine arabinoside : functional relevance of mitochondria in Aplidin-induced cytotoxicity

Journal article

Open access

Peer reviewed

Aplidin synergizes with cytosine arabinoside : functional relevance of mitochondria in Aplidin-induced cytotoxicity

R Humeniuk, L. G Menon, D Banerjee, P. J Mishra, G Saydam, G. S. A LONGO-SORBELLO, Y Elisseyeff, L. D Lewis, M Aracil, J Jimeno, …

Leukemia, Vol.21(12), pp.2399-2405

2007

DOI: https://doi.org/10.1038/sj.leu.2404911

PMID: 17713546

Abstract

Biological and medical sciences

Hematologic and hematopoietic diseases

Medical sciences

Files and links (1)

url

https://doi.org/10.1038/sj.leu.2404911View

Version of Record (VoR) Open

Metrics

10 Record Views

16 Times Cited - Web of Science

Details

Title: Aplidin synergizes with cytosine arabinoside : functional relevance of mitochondria in Aplidin-induced cytotoxicity
Creators: R Humeniuk - Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
L. G Menon - Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
D Banerjee - Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
P. J Mishra - Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
G Saydam - Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
G. S. A LONGO-SORBELLO - Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
Y Elisseyeff - Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
L. D Lewis - Section of Clinical Pharmacology, Department of Medicine, Dartmouth Medical School and Dartmouth Hitchcock Medical Center, Lebanon, NH, United States
M Aracil - PharmaMar R&D, Madrid, Spain
J Jimeno - PharmaMar R&D, Madrid, Spain
J. R Bertino - Department of Medicine and Pharmacology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, United States
Publication Details: Leukemia, Vol.21(12), pp.2399-2405
Date published: 2007
Publisher: Nature Publishing
Academic Unit: Bertino Office
Language: English
Resource Type: Journal article
Identifiers: 991031665674704646